Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort.

Journal of the National Medical Association - 1 Dec 2019

Ettienne Earl B, Ofoegbu Adaku, Maneno Mary K, Briggs Jayla, Ezeude Ginikannwa, Williams Simisola, Walker Casey, Chapman Edwin

Abstract excerpt

Opioid use disorder (OUD) constitutes a significant public health burden as opioid overdose deaths have continued to rise in the United States. Although treatment modalities are available to manage OUD, some patients experience challenges achieving their OUD management goals. Some of these challenges may be attributable to inherited genetic variations, or polymorphisms, on the genes that code for proteins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP3A

Share to Decision Support Systems, Clinical

Share to Dose-Response Relationship, Drug

Share to Narcotic Antagonists

Share to Opioid-Related Disorders

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 31676110
DOI: 10.1016/j.jnma.2019.09.006
PMCID: PMC8815013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort.PMID 31676110Read ↗

Pharmacogenetics of Opioid Use Disorder Treatment.Semantic proximity Read ↗

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.Semantic proximity Read ↗

Association of OPRM1 Functional Coding Variant With Opioid Use DisorderSemantic proximity Read ↗

Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.Semantic proximity Read ↗

Identification of a sex-stratified genetic algorithm for opioid addiction risk.Semantic proximity Read ↗

A review of the existing literature on buprenorphine pharmacogenomics.Semantic proximity Read ↗

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Semantic proximity Read ↗

The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.Semantic proximity Read ↗

Symbiotic relationship of pharmacogenetics and drugs of abuse.Semantic proximity Read ↗

Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.Semantic proximity Read ↗

Substance abuse in the United States: findings from recent epidemiologic studies.Semantic proximity Read ↗

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.